Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 05-2018 | 02-2018 | 11-2017 | 08-2017 | 05-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 326 | 525 | 412 | 573 | 228 |
| Receivables | 17 | 1 | 1 | N/A | N/A |
| TOTAL | $400 | $540 | $430 | $574 | $228 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 1 | N/A | N/A |
| TOTAL | $1 | $1 | $1 | $N/A | $N/A |
| Total Assets | $401 | $541 | $430 | $574 | $228 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 492 | 156 | 136 | 30 | 310 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 2 |
| TOTAL | $492 | $156 | $136 | $29 | $342 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $492 | $156 | $136 | $29 | $342 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47 | 47 | 43 | N/A | 36 |
| Common Shares | 13 | 12 | 11 | 11 | 10 |
| Retained earnings | -1,949 | -1,201 | -572 | -295 | -179 |
| Other shareholders' equity | -12 | -2 | -1 | 1 | 0 |
| TOTAL | $-91 | $385 | $294 | $545 | $-114 |
| Total Liabilities And Equity | $401 | $541 | $430 | $574 | $228 |